Navigation Links
Cell Therapeutics, Inc. (CTI) Plans to Submit Supplemental Biologics License Application (sBLA) for ZEVALIN(R) Consolidation of First Remission in Advanced Stage Follicular Lymphoma in 2008
Date:11/27/2007

29 presentations on ZEVALIN(R) scheduled at American Society of Hematology

(ASH) Annual Meeting

SEATTLE, Nov. 27 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc. (CTI) (Nasdaq: CTIC; MTAX) today announced it intends to utilize the results of the phase III first-line indolent trial of ZEVALIN (Ibritumomab Tiuxetan), known as the FIT trial, for submission to the United States Food and Drug Administration (FDA) for potential approval in the consolidation of first remissions following chemotherapy for patients with follicular non-Hodgkin's lymphoma (NHL). CTI has signed an agreement to acquire the U.S. marketing, sales and development rights to ZEVALIN, however, that acquisition has not yet been completed and remains subject to closing conditions, including obtaining certain third party consents, and until the transaction is closed, ZEVALIN remains a product and trademark of Biogen Idec, Inc. CTI expects the acquisition to close by the end of November and as such is hosting a booth at the ASH meetings. The results of the FIT trial will be presented in an oral session on Monday, December 10 at 3:30 p.m. (Eastern) at the 49th Annual Meeting of the American Society of Hematology (ASH), being held December 8-11, 2007 in Atlanta.

Bayer Schering recently announced it had submitted the FIT results to the EMEA for consideration for a new indication for the product in the European Union (EU). "With our commercial leadership now on board we look forward to the prospects of working closely with Bayer-Schering in providing the support for the Zevalin brand that this important therapeutic deserves," said James A. Bianco, M.D., President and CEO of CTI.

Other presentations at ASH, includ
'/>"/>

SOURCE Cell Therapeutics, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine news :

1. Sontra Medical Corporation Changes Name to Echo Therapeutics, Inc.
2. Cell Therapeutics, Inc. (CTI) to Present at BIO Investor Forum
3. Horizon Therapeutics, Inc. Scheduled to Present at Upcoming BioPartnering Europe Meeting
4. Cell Therapeutics, Inc. (CTI) CIBC and Rodman & Renshaw Healthcare Conference Presentations to be Webcast
5. Cell Therapeutics, Inc. (CTI) to Report Third Quarter Financial Results on November 8
6. Cell Therapeutics, Inc. (CTI) Reports Recent Accomplishments and Third Quarter 2007 Financial Results
7. Cell Therapeutics, Inc. (CTI) Appoints Jim Fong as Vice President, Commercial Operations
8. InteKrin Therapeutics, Inc. Appoints Former Amgen Clinical Development Executive Chief Medical Officer
9. Clinical Trial Investigators Update Wall Street on Progress and Prospects of Cell Therapeutics, Inc.s Drug Pipeline
10. Health Plans Increase Use of Health Incentives
11. Area Health Care Providers Announce Plans to Integrate Services
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/30/2014)... (PRWEB) August 30, 2014 The Plastic ... in New Jersey and even in the U.S. to ... takes inches off of patients’ waists with deep-tissue heating. ... in small sections, Vanquish is more inclusive to target ... Patients lay comfortably under panels about one inch away ...
(Date:8/30/2014)... NY (PRWEB) August 30, 2014 ... U.S. Open Tennis Championship tickets in NYC. ... appreciation promo/coupon code US-OPEN-2014 for all day session, evening ... and group sales for this prestigious Grand Slam Tournament. ... below: , 8/30/14 , US Open Tennis Championship: Men's/Women's ...
(Date:8/30/2014)... (PRWEB) August 30, 2014 Acne is a common ... cases acne is nothing more than a daily nuisance, for some, ... Severe cases of acne can even lead to dramatic mood swings ... to try anything to clear up their skin. In some cases, ... and money through trial and error, those on a quest for ...
(Date:8/30/2014)... 2014 Hundreds of Byetta lawsuits ( ... move forward in U.S. courts, Bernstein Liebhard LLP reports. ... July 31, 2014, Byetta and Bydureon (an extended-release version ... claims that allege the drugs caused pancreatitis, pancreatic cancer ... these claims are pending in a multidistrict litigation underway ...
(Date:8/30/2014)... Randy Dotinga HealthDay ... About one in five patients operated on for broken bones ... surgery, a new study finds. Less-educated patients and ... more likely to be "doctor shoppers," said study lead author ... Ky. Overall, he said, the study suggests that doctors aren,t ...
Breaking Medicine News(10 mins):Health News:NJ Top Docs Presents, The Plastic Surgery Group 2Health News:US Open Tennis Tickets: Ticket Down Slashes Ticket Prices for Labor Day Weekend Sessions and More 2Health News:US Open Tennis Tickets: Ticket Down Slashes Ticket Prices for Labor Day Weekend Sessions and More 3Health News:US Open Tennis Tickets: Ticket Down Slashes Ticket Prices for Labor Day Weekend Sessions and More 4Health News:US Open Tennis Tickets: Ticket Down Slashes Ticket Prices for Labor Day Weekend Sessions and More 5Health News:Acne Treatment Reviews Added to Popular Treatment Website 2Health News:Byetta Lawsuits Move Forward, as Bernstein Liebhard LLP Notes Settlements in More than 80 Cases 2Health News:Byetta Lawsuits Move Forward, as Bernstein Liebhard LLP Notes Settlements in More than 80 Cases 3Health News:'Doctor-Shopping' for Painkillers Common After Broken-Bone Surgery, Study Finds 2Health News:'Doctor-Shopping' for Painkillers Common After Broken-Bone Surgery, Study Finds 3
... Payors To,Become Engaged and Accountable, WASHINGTON, Sept. 9 ... Medco Health Solutions, Inc. (NYSE: MHS ) Chairman,and ... for fixing,America,s inefficient health care system that, for the ... the problem. Unifying the strengths,of both the public and ...
... not in a state of craving, they may underestimate intensity ... (HealthDay News) -- If you,re not craving a hit of ... battle just got a little tougher, say researchers at the ... have observed previously that the idea of smoking a cigarette ...
... Transcend Medical, Inc., an,ophthalmic device company dedicated to delivering ... J. Walsh was named as President,and Chief Executive Officer ... Chairman of the Board of Directors., "Brian is ... de Juan,Jr., M.D., the founder of ForSight Labs, the ...
... Delta Dental funding pioneer studies to improve oral health for youngsters ... ... Mich., Sept. 9 The affiliated companies of,Delta Dental of Michigan, ... if sugarless lollipops containing,licorice extract can reduce the bacteria that causes ...
... Award To Johns Hopkins University Scientists, LISBON, Portugal ... of the largest global science foundations, today announced,the recipients ... ($1.4 million),Antonio Champalimaud Vision Award, referred to as the ... A.P.J. Kalam, is the largest,monetary prize in the field ...
... stop on AHIP,s listening tour; Reducing health disparities ... America,s Health,Insurance Plans, (AHIP) Campaign for an American ... which local government, business,health care and community leaders ... disparities in care experienced by diverse communities., ...
Cached Medicine News:Health News:Medco CEO Unveils Pragmatic Blueprint for Health Care Reform; Reducing Costs by Upwards of $1 Trillion 2Health News:Medco CEO Unveils Pragmatic Blueprint for Health Care Reform; Reducing Costs by Upwards of $1 Trillion 3Health News:Medco CEO Unveils Pragmatic Blueprint for Health Care Reform; Reducing Costs by Upwards of $1 Trillion 4Health News:Study Probes Why Smokers Find It Hard to Quit 2Health News:Transcend Medical Announces New President and CEO and Appointment of Chairman of the Board 2Health News:Transcend Medical Announces New President and CEO and Appointment of Chairman of the Board 3Health News:How Many Licks Does it Take to Reduce Tooth Decay? 2Health News:How Many Licks Does it Take to Reduce Tooth Decay? 3Health News:How Many Licks Does it Take to Reduce Tooth Decay? 4Health News:Two U.S. Researchers Win Prestigious International Science Award 2Health News:Two U.S. Researchers Win Prestigious International Science Award 3Health News:Health Insurance Industry Hosts Roundtable Discussion on Health Care Reform in Albuquerque 2Health News:Health Insurance Industry Hosts Roundtable Discussion on Health Care Reform in Albuquerque 3
(Date:8/29/2014)... , Aug. 29, 2014 Thoratec Corporation ... device-based mechanical circulatory support therapies to save, support and ... in the 2014 Morgan Stanley Global Healthcare Conference on ... , President and Chief Executive Officer, will provide an ... Daylight Time (9:55 a.m., Pacific Daylight Time).   ...
(Date:8/29/2014)... 2014 Research and Markets has ... Industry Report, 2014-2017" report to their offering. ... proportion of reimbursement for medical expenses, the Chinese orthopedic ... scale presenting a CAGR of 19.2% during 2009-2013. Trauma ... segments of orthopedic instruments in China ...
(Date:8/29/2014)... , Aug. 29, 2014 Research and Markets ... Drug Pipeline Insight 2014" report to their offering. ... US is one of the largest segments of pharmaceuticals industry. ... rate, while the available therapies were unable to meet the ... the market for CNS disorder, especially over the past two ...
Breaking Medicine Technology:China Orthopedic Instrument Industry Report, 2014-2017 2US CNS Disorders Drug Pipeline Insight 2014 2
... MINNEAPOLIS, Oct. 4 BridgePoint Medical, Inc., a ... catheter-based systems for chronic total occlusion (CTO) recanalization, ... 16 center, 147 patient U.S. FAST-CTOs (Facilitated Antegrade ... Occlusions) study was designed to assess the safety ...
... a blocked heart artery isn,t the only procedure that ... in a thigh artery and into a heart artery. ... (Logo: http://photos.prnewswire.com/prnh/20100222/AHSALOGO ) ... process of creating a hole in an "access artery" ...
Cached Medicine Technology:BridgePoint Medical®, Inc. Completes and Submits to FDA in the U.S. FAST-CTOs With the CrossBoss® and Stingray® CTO Recanalization System 2BridgePoint Medical®, Inc. Completes and Submits to FDA in the U.S. FAST-CTOs With the CrossBoss® and Stingray® CTO Recanalization System 3Guidelines on Using Artery-Closing Devices: Devices Are OK, But More Research Needed 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: